Lilach Koren
- Molecular Biology
- Biomedical Engineering
- Immunology
- Pulmonary and Respiratory Medicine
- Cancer Research
- Co-authors
- Ami AronheimTsonwin HaiAvi SchroederOfer ElhananiIzhak KehatGaloz KanetiRoy KalfonAssaf Zinger
- Topics
- Nanoplatforms for cancer theranostics (5 papers)Nanoparticle-Based Drug Delivery (4 papers)Signaling Pathways in Disease (3 papers)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Lilach Koren
17 papers receiving 400 citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 174
- Biomedical Engineering 88
- Immunology 74
- Pulmonary and Respiratory Medicine 59
- Cancer Research 55
Countries citing papers authored by Lilach Koren
This map shows the geographic impact of Lilach Koren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilach Koren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilach Koren more than expected).
Fields of papers citing papers by Lilach Koren
This network shows the impact of papers produced by Lilach Koren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilach Koren. The network helps show where Lilach Koren may publish in the future.
Co-authorship network of co-authors of Lilach Koren
This figure shows the co-authorship network connecting the top 25 collaborators of Lilach Koren. A scholar is included among the top collaborators of Lilach Koren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lilach Koren. Lilach Koren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 23 | |
| 5 | 58 | |
| 6 | 12 | |
| 7 | 2 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | 2 | |
| 12 | 63 | |
| 13 | 70 | |
| 14 | 13 | |
| 15 | 18 | |
| 16 | 40 | |
| 17 | 24 | |
| 18 | 36 | |
| 19 | 25 | |
| 20 | 15 |
About Lilach Koren
Lilach Koren is a scholar working on Biomaterials, Immunology and Biotechnology, having authored 22 papers that have together received 408 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and Signaling Pathways in Disease (3 papers). The work is most often cited by research in Cancer Research (55 citations), Biomaterials (46 citations) and Immunology (74 citations). Lilach Koren has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Ami Aronheim, Tsonwin Hai, Avi Schroeder, Ofer Elhanani, Izhak Kehat, Galoz Kaneti, Roy Kalfon, Assaf Zinger, Janna Shainsky‐Roitman and Sharon Aviram. Their work appears in journals such as SHILAP Revista de lepidopterología, ACS Nano and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.